APO Research
Talk to an analyst

APO RESEARCH · REPORT

Huntington's Disease Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Huntington's Disease Therapeutics Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchHuntington's Disease Therapeutics Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Huntington's Disease Therapeutics Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Huntington's Disease Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Huntington's Disease Therapeutics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Huntington's Disease Therapeutics Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Huntington's Disease Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Huntington's Disease Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Huntington's Disease Therapeutics include Teva Pharmaceutical Industries, Prana Biotechnology, Horizon Pharma, H. Lundbeck and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Huntington's Disease Therapeutics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Huntington's Disease Therapeutics market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Huntington's Disease Therapeutics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Huntington's Disease Therapeutics.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Huntington's Disease Therapeutics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Huntington's Disease Therapeutics Market by Company

Teva Pharmaceutical Industries

Prana Biotechnology

Horizon Pharma

H. Lundbeck

F. Hoffmann-La Roche

Huntington's Disease Therapeutics Segment by Type

Antidepressants

Anticonvulsants

Antipsychotics

Antidopaminergics

Huntington's Disease Therapeutics Segment by Application

Clinics

Diagnostic Centers

Hospitals

Huntington's Disease Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Huntington's Disease Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Huntington's Disease Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Huntington's Disease Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Huntington's Disease Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Huntington's Disease Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antidepressants Table 2. Major Company of Anticonvulsants Table 3. Major Company of Antipsychotics Table 4. Major Company of Antidopaminergics Table 5. Global Huntington's Disease Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Huntington's Disease Therapeutics Sales by Type (2021-2026) & (k units) Table 7. Global Huntington's Disease Therapeutics Sales Market Share in Volume by Type (2021-2026) Table 8. Global Huntington's Disease Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 9. Global Huntington's Disease Therapeutics Sales Market Share in Value by Type (2021-2026) Table 10. Global Huntington's Disease Therapeutics Price by Type (2021-2026) & (US$/unit) Table 11. Global Huntington's Disease Therapeutics Sales by Type (2027-2032) & (k units) Table 12. Global Huntington's Disease Therapeutics Sales Market Share in Volume by Type (2027-2032) Table 13. Global Huntington's Disease Therapeutics Sales by Type (2027-2032) & (US$ Million) Table 14. Global Huntington's Disease Therapeutics Sales Market Share in Value by Type (2027-2032) Table 15. Global Huntington's Disease Therapeutics Price by Type (2027-2032) & (US$/unit) Table 16. North America Huntington's Disease Therapeutics Sales by Type (2021-2026) & (k units) Table 17. North America Huntington's Disease Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Huntington's Disease Therapeutics Sales by Type (2021-2026) & (k units) Table 19. Europe Huntington's Disease Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Huntington's Disease Therapeutics Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Huntington's Disease Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Huntington's Disease Therapeutics Sales by Type (2021-2026) & (k units) Table 23. Latin America Huntington's Disease Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Huntington's Disease Therapeutics Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Huntington's Disease Therapeutics Sales by Type (2021-2026) & (US$ Million) Table 26. Huntington's Disease Therapeutics Industry Trends Table 27. Huntington's Disease Therapeutics Industry Drivers Table 28. Huntington's Disease Therapeutics Industry Opportunities and Challenges Table 29. Huntington's Disease Therapeutics Industry Restraints Table 30. Global Huntington's Disease Therapeutics Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Huntington's Disease Therapeutics Revenue Market Share by Company (2021-2026) Table 32. Global Huntington's Disease Therapeutics Sales by Company (2021-2026) & (k units) Table 33. Global Huntington's Disease Therapeutics Sales Share by Company (2021-2026) Table 34. Global Huntington's Disease Therapeutics Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Huntington's Disease Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Huntington's Disease Therapeutics Major Company Production Sites and Headquarters Table 37. Global Huntington's Disease Therapeutics Company, Product Type & Application Table 38. Global Huntington's Disease Therapeutics Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Huntington's Disease Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Huntington's Disease Therapeutics Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Huntington's Disease Therapeutics Sales by Region (2021-2026) & (k units) Table 43. Global Huntington's Disease Therapeutics Sales Market Share in Volume by Region (2021-2026) Table 44. Global Huntington's Disease Therapeutics Sales by Region (2021-2026) & (US$ Million) Table 45. Global Huntington's Disease Therapeutics Sales Market Share in Value by Region (2021-2026) Table 46. Global Huntington's Disease Therapeutics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Huntington's Disease Therapeutics Sales by Region (2027-2032) & (k units) Table 48. Global Huntington's Disease Therapeutics Sales Market Share in Volume by Region (2027-2032) Table 49. Global Huntington's Disease Therapeutics Sales by Region (2027-2032) & (US$ Million) Table 50. Global Huntington's Disease Therapeutics Sales Market Share in Value by Region (2027-2032) Table 51. Global Huntington's Disease Therapeutics Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Huntington's Disease Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Huntington's Disease Therapeutics Sales by Application (2021-2026) & (k units) Table 54. Global Huntington's Disease Therapeutics Sales Market Share in Volume by Application (2021-2026) Table 55. Global Huntington's Disease Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 56. Global Huntington's Disease Therapeutics Sales Market Share in Value by Application (2021-2026) Table 57. Global Huntington's Disease Therapeutics Price by Application (2021-2026) & (US$/unit) Table 58. Global Huntington's Disease Therapeutics Sales by Application (2027-2032) & (k units) Table 59. Global Huntington's Disease Therapeutics Sales Market Share in Volume by Application (2027-2032) Table 60. Global Huntington's Disease Therapeutics Sales by Application (2027-2032) & (US$ Million) Table 61. Global Huntington's Disease Therapeutics Sales Market Share in Value by Application (2027-2032) Table 62. Global Huntington's Disease Therapeutics Price by Application (2027-2032) & (US$/unit) Table 63. North America Huntington's Disease Therapeutics Sales by Application (2021-2026) & (k units) Table 64. North America Huntington's Disease Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Huntington's Disease Therapeutics Sales by Application (2021-2026) & (k units) Table 66. Europe Huntington's Disease Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Huntington's Disease Therapeutics Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Huntington's Disease Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Huntington's Disease Therapeutics Sales by Application (2021-2026) & (k units) Table 70. Latin America Huntington's Disease Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Huntington's Disease Therapeutics Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Huntington's Disease Therapeutics Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Pharmaceutical Industries Company Information Table 74. Teva Pharmaceutical Industries Business Overview Table 75. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Portfolio Table 77. Teva Pharmaceutical Industries Recent Development Table 78. Prana Biotechnology Company Information Table 79. Prana Biotechnology Business Overview Table 80. Prana Biotechnology Huntington's Disease Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Prana Biotechnology Huntington's Disease Therapeutics Product Portfolio Table 82. Prana Biotechnology Recent Development Table 83. Horizon Pharma Company Information Table 84. Horizon Pharma Business Overview Table 85. Horizon Pharma Huntington's Disease Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Horizon Pharma Huntington's Disease Therapeutics Product Portfolio Table 87. Horizon Pharma Recent Development Table 88. H. Lundbeck Company Information Table 89. H. Lundbeck Business Overview Table 90. H. Lundbeck Huntington's Disease Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. H. Lundbeck Huntington's Disease Therapeutics Product Portfolio Table 92. H. Lundbeck Recent Development Table 93. F. Hoffmann-La Roche Company Information Table 94. F. Hoffmann-La Roche Business Overview Table 95. F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Portfolio Table 97. F. Hoffmann-La Roche Recent Development Table 98. North America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 99. North America Huntington's Disease Therapeutics Sales by Country (2021-2026) & (k units) Table 100. North America Huntington's Disease Therapeutics Sales Market Share by Country (2021-2026) Table 101. North America Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 102. North America Huntington's Disease Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 103. North America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Huntington's Disease Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Huntington's Disease Therapeutics Market Share by Country (2021-2026) Table 106. North America Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Huntington's Disease Therapeutics Market Share Forecast by Country (2027-2032) Table 108. Europe Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 109. Europe Huntington's Disease Therapeutics Sales by Country (2021-2026) & (k units) Table 110. Europe Huntington's Disease Therapeutics Sales Market Share by Country (2021-2026) Table 111. Europe Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 112. Europe Huntington's Disease Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 113. Europe Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Europe Huntington's Disease Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 115. Europe Huntington's Disease Therapeutics Market Share by Country (2021-2026) Table 116. Europe Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Europe Huntington's Disease Therapeutics Market Share Forecast by Country (2027-2032) Table 118. Asia-Pacific Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 119. Asia-Pacific Huntington's Disease Therapeutics Sales by Country (2021-2026) & (k units) Table 120. Asia-Pacific Huntington's Disease Therapeutics Sales Market Share by Country (2021-2026) Table 121. Asia-Pacific Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 122. Asia-Pacific Huntington's Disease Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Huntington's Disease Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Huntington's Disease Therapeutics Market Share by Country (2021-2026) Table 126. Asia-Pacific Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Huntington's Disease Therapeutics Market Share Forecast by Country (2027-2032) Table 128. Latin America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. Latin America Huntington's Disease Therapeutics Sales by Country (2021-2026) & (k units) Table 130. Latin America Huntington's Disease Therapeutics Sales Market Share by Country (2021-2026) Table 131. Latin America Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 132. Latin America Huntington's Disease Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 133. Latin America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Huntington's Disease Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Huntington's Disease Therapeutics Market Share by Country (2021-2026) Table 136. Latin America Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Huntington's Disease Therapeutics Market Share Forecast by Country (2027-2032) Table 138. Middle East and Africa Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2021-2026) & (k units) Table 140. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share by Country (2021-2026) Table 141. Middle East and Africa Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032) & (k units) Table 142. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Huntington's Disease Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East and Africa Huntington's Disease Therapeutics Market Share by Country (2021-2026) Table 146. Middle East and Africa Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Huntington's Disease Therapeutics Market Share Forecast by Country (2027-2032) Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Huntington's Disease Therapeutics Distributors List Table 151. Huntington's Disease Therapeutics Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Huntington's Disease Therapeutics Image Figure 2. Global Huntington's Disease Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Huntington's Disease Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Huntington's Disease Therapeutics Sales (2021-2032) & (k units) Figure 5. Antidepressants Image Figure 6. Global Antidepressants Sales YoY Growth (2021-2032) & (k units) Figure 7. Anticonvulsants Image Figure 8. Global Anticonvulsants Sales YoY Growth (2021-2032) & (k units) Figure 9. Antipsychotics Image Figure 10. Global Antipsychotics Sales YoY Growth (2021-2032) & (k units) Figure 11. Antidopaminergics Image Figure 12. Global Antidopaminergics Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Huntington's Disease Therapeutics Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Huntington's Disease Therapeutics Market Share by Type 2025 VS 2032 Figure 15. North America Huntington's Disease Therapeutics Sales Market Share in Volume by Type in 2025 Figure 16. North America Huntington's Disease Therapeutics Sales Market Share in Value by Type in 2025 Figure 17. Europe Huntington's Disease Therapeutics Sales Market Share in Volume by Type in 2025 Figure 18. Europe Huntington's Disease Therapeutics Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Huntington's Disease Therapeutics Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Huntington's Disease Therapeutics Sales Market Share in Value by Type in 2025 Figure 21. Latin America Huntington's Disease Therapeutics Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Huntington's Disease Therapeutics Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Huntington's Disease Therapeutics Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 29. Diagnostic Centers Image Figure 30. Global Diagnostic Centers Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospitals Image Figure 32. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Huntington's Disease Therapeutics Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Huntington's Disease Therapeutics Market Share by Application 2025 VS 2032 Figure 35. North America Huntington's Disease Therapeutics Sales Market Share in Volume by Application in 2025 Figure 36. North America Huntington's Disease Therapeutics Sales Market Share in Value by Application in 2025 Figure 37. Europe Huntington's Disease Therapeutics Sales Market Share in Volume by Application in 2025 Figure 38. Europe Huntington's Disease Therapeutics Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Huntington's Disease Therapeutics Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Huntington's Disease Therapeutics Sales Market Share in Value by Application in 2025 Figure 41. Latin America Huntington's Disease Therapeutics Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Huntington's Disease Therapeutics Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Huntington's Disease Therapeutics Sales Market Share in Value by Application in 2025 Figure 45. North America Huntington's Disease Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Huntington's Disease Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Huntington's Disease Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Huntington's Disease Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Huntington's Disease Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Huntington's Disease Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Huntington's Disease Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Huntington's Disease Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Huntington's Disease Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Huntington's Disease Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Huntington's Disease Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Huntington's Disease Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Huntington's Disease Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Huntington's Disease Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Huntington's Disease Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Huntington's Disease Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Huntington's Disease Therapeutics Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Huntington's Disease Therapeutics Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Huntington's Disease Therapeutics Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Huntington's Disease Therapeutics Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Huntington's Disease Therapeutics Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Huntington's Disease Therapeutics Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Antidepressants
  • Anticonvulsants
  • Antipsychotics
  • Antidopaminergics
Applications
  • Clinics
  • Diagnostic Centers
  • Hospitals
Companies covered
  • Teva Pharmaceutical Industries
  • Prana Biotechnology
  • Horizon Pharma
  • H. Lundbeck
  • F. Hoffmann-La Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Huntington's Disease Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Huntington's Disease Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Huntington's Disease Therapeutics Market by Type
  6. 1.3.1 Antidepressants
  7. 1.3.2 Anticonvulsants
  8. 1.3.3 Antipsychotics
  9. 1.3.4 Antidopaminergics
  10. 1.4 Global Huntington's Disease Therapeutics Market Size by Type
  11. 1.4.1 Global Huntington's Disease Therapeutics Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Huntington's Disease Therapeutics Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Huntington's Disease Therapeutics Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Huntington's Disease Therapeutics Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Huntington's Disease Therapeutics Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Huntington's Disease Therapeutics Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Huntington's Disease Therapeutics Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Huntington's Disease Therapeutics Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Huntington's Disease Therapeutics Industry Trends
  2. 2.2 Huntington's Disease Therapeutics Industry Drivers
  3. 2.3 Huntington's Disease Therapeutics Industry Opportunities and Challenges
  4. 2.4 Huntington's Disease Therapeutics Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Huntington's Disease Therapeutics Revenue (2021-2026)
  2. 3.2 Global Top Players by Huntington's Disease Therapeutics Sales (2021-2026)
  3. 3.3 Global Top Players by Huntington's Disease Therapeutics Price (2021-2026)
  4. 3.4 Global Huntington's Disease Therapeutics Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Huntington's Disease Therapeutics Major Company Production Sites & Headquarters
  6. 3.6 Global Huntington's Disease Therapeutics Company, Product Type & Application
  7. 3.7 Global Huntington's Disease Therapeutics Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Huntington's Disease Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Huntington's Disease Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Huntington's Disease Therapeutics Tier 1, Tier 2, and Tier 3
4 Huntington's Disease Therapeutics Regional Status and Outlook
  1. 4.1 Global Huntington's Disease Therapeutics Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Huntington's Disease Therapeutics Historic Market Size by Region
  3. 4.2.1 Global Huntington's Disease Therapeutics Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Huntington's Disease Therapeutics Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Huntington's Disease Therapeutics Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Huntington's Disease Therapeutics Forecasted Market Size by Region
  7. 4.3.1 Global Huntington's Disease Therapeutics Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Huntington's Disease Therapeutics Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Huntington's Disease Therapeutics Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Huntington's Disease Therapeutics by Application
  1. 5.1 Huntington's Disease Therapeutics Market by Application
  2. 5.1.1 Clinics
  3. 5.1.2 Diagnostic Centers
  4. 5.1.3 Hospitals
  5. 5.2 Global Huntington's Disease Therapeutics Market Size by Application
  6. 5.2.1 Global Huntington's Disease Therapeutics Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Huntington's Disease Therapeutics Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Huntington's Disease Therapeutics Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Huntington's Disease Therapeutics Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Huntington's Disease Therapeutics Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Huntington's Disease Therapeutics Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Huntington's Disease Therapeutics Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Huntington's Disease Therapeutics Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Prana Biotechnology
  8. 6.2.1 Prana Biotechnology Company Information
  9. 6.2.2 Prana Biotechnology Business Overview
  10. 6.2.3 Prana Biotechnology Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Prana Biotechnology Huntington's Disease Therapeutics Product Portfolio
  12. 6.2.5 Prana Biotechnology Recent Developments
  13. 6.3 Horizon Pharma
  14. 6.3.1 Horizon Pharma Company Information
  15. 6.3.2 Horizon Pharma Business Overview
  16. 6.3.3 Horizon Pharma Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Horizon Pharma Huntington's Disease Therapeutics Product Portfolio
  18. 6.3.5 Horizon Pharma Recent Developments
  19. 6.4 H. Lundbeck
  20. 6.4.1 H. Lundbeck Company Information
  21. 6.4.2 H. Lundbeck Business Overview
  22. 6.4.3 H. Lundbeck Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 H. Lundbeck Huntington's Disease Therapeutics Product Portfolio
  24. 6.4.5 H. Lundbeck Recent Developments
  25. 6.5 F. Hoffmann-La Roche
  26. 6.5.1 F. Hoffmann-La Roche Company Information
  27. 6.5.2 F. Hoffmann-La Roche Business Overview
  28. 6.5.3 F. Hoffmann-La Roche Huntington's Disease Therapeutics Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 F. Hoffmann-La Roche Huntington's Disease Therapeutics Product Portfolio
  30. 6.5.5 F. Hoffmann-La Roche Recent Developments
7 North America by Country
  1. 7.1 North America Huntington's Disease Therapeutics Sales by Country
  2. 7.1.1 North America Huntington's Disease Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Huntington's Disease Therapeutics Sales by Country (2021-2026)
  4. 7.1.3 North America Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032)
  5. 7.2 North America Huntington's Disease Therapeutics Market Size by Country
  6. 7.2.1 North America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Huntington's Disease Therapeutics Market Size by Country (2021-2026)
  8. 7.2.3 North America Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Huntington's Disease Therapeutics Sales by Country
  2. 8.1.1 Europe Huntington's Disease Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Huntington's Disease Therapeutics Sales by Country (2021-2026)
  4. 8.1.3 Europe Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Huntington's Disease Therapeutics Market Size by Country
  6. 8.2.1 Europe Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Huntington's Disease Therapeutics Market Size by Country (2021-2026)
  8. 8.2.3 Europe Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Huntington's Disease Therapeutics Sales by Country
  2. 9.1.1 Asia-Pacific Huntington's Disease Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Huntington's Disease Therapeutics Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Huntington's Disease Therapeutics Market Size by Country
  6. 9.2.1 Asia-Pacific Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Huntington's Disease Therapeutics Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Huntington's Disease Therapeutics Sales by Country
  2. 10.1.1 South America Huntington's Disease Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Huntington's Disease Therapeutics Sales by Country (2021-2026)
  4. 10.1.3 South America Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032)
  5. 10.2 South America Huntington's Disease Therapeutics Market Size by Country
  6. 10.2.1 South America Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Huntington's Disease Therapeutics Market Size by Country (2021-2026)
  8. 10.2.3 South America Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Huntington's Disease Therapeutics Sales by Country
  2. 11.1.1 Middle East and Africa Huntington's Disease Therapeutics Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Huntington's Disease Therapeutics Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Huntington's Disease Therapeutics Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Huntington's Disease Therapeutics Market Size by Country
  6. 11.2.1 Middle East and Africa Huntington's Disease Therapeutics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Huntington's Disease Therapeutics Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Huntington's Disease Therapeutics Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Huntington's Disease Therapeutics Value Chain Analysis
  2. 12.1.1 Huntington's Disease Therapeutics Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Huntington's Disease Therapeutics Production Mode & Process
  7. 12.2 Huntington's Disease Therapeutics Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Huntington's Disease Therapeutics Distributors
  10. 12.2.3 Huntington's Disease Therapeutics Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst